1
|
Thissen J, Klassen MD, Constantinidis P, Hacker MC, Breitkreutz J, Teutenberg T, Fischer B. Online Coupling of Size Exclusion Chromatography to Capillary Enhanced Raman Spectroscopy for the Analysis of Proteins and Biopharmaceutical Drug Products. Anal Chem 2023; 95:17868-17877. [PMID: 38050672 DOI: 10.1021/acs.analchem.3c03991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/06/2023]
Abstract
The online coupling of size exclusion chromatography (SEC) to capillary enhanced Raman spectroscopy (CERS) based on a liquid core waveguide (LCW) flow cell was applied for the first time to assess the higher-order structure of different proteins. This setup allows recording of Raman spectra of the monomeric protein within complex mixtures, since SEC enables the separation of the monomeric protein from matrix components such as excipients of a biopharmaceutical product and higher molecular weight species (e.g., aggregates). The acquired Raman spectra were used for structural elucidation of well characterized proteins such as bovine serum albumin, hen egg white lysozyme, and β-lactoglobulin and of the monoclonal antibody rituximab in a medicinal product. Additionally, the CERS detection of the disaccharide sucrose, which is used as a stabilizing excipient, was quantified to achieve a limit of detection (LOD) of 120 μg and a limit of quantification (LOQ) of 363 μg injected on the column.
Collapse
Affiliation(s)
- Jana Thissen
- Institut für Umwelt & Energie, Technik & Analytik e.V. (IUTA), Bliersheimer Straße 58-60, 47229 Duisburg, Germany
- Institute of Pharmaceutics and Biopharmaceutics, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| | - Martin D Klassen
- Institut für Umwelt & Energie, Technik & Analytik e.V. (IUTA), Bliersheimer Straße 58-60, 47229 Duisburg, Germany
| | - Philipp Constantinidis
- Institut für Umwelt & Energie, Technik & Analytik e.V. (IUTA), Bliersheimer Straße 58-60, 47229 Duisburg, Germany
| | - Michael C Hacker
- Institute of Pharmaceutics and Biopharmaceutics, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| | - Jörg Breitkreutz
- Institute of Pharmaceutics and Biopharmaceutics, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| | - Thorsten Teutenberg
- Institut für Umwelt & Energie, Technik & Analytik e.V. (IUTA), Bliersheimer Straße 58-60, 47229 Duisburg, Germany
| | - Björn Fischer
- Institute of Pharmaceutics and Biopharmaceutics, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany
| |
Collapse
|
2
|
Knoll L, Thiesen J, Klassen MD, Reinders LMH, Tuerk J, Kraemer I. In-use stability of ready-to-administer daratumumab subcutaneous injection solution in plastic syringes. Eur J Hosp Pharm 2023:ejhpharm-2023-003928. [PMID: 37879731 DOI: 10.1136/ejhpharm-2023-003928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Accepted: 10/03/2023] [Indexed: 10/27/2023] Open
Abstract
OBJECTIVE In multiple myeloma patients, daratumumab is preferably injected subcutaneously. The summary of product characteristics of daratumumab subcutaneous injection solution specifies physicochemical stability for the prepared syringe for 24 hours at 2-8°C protected from light, and another 12 hours at room temperature (15-25°C) in ambient light conditions. The aim of this study was to determine the in-use stability of ready-to-administer daratumumab subcutaneous injection solution in different types of syringe and different conditions over a 28-day period. METHODS Daratumumab subcutaneous (DARZALEX 1800 mg) injection solution was withdrawn into disposable three-piece Luer-Lock syringes (20 mL, 50 mL), capped, and stored light protected at 2-8°C or at room temperature (22±2°C) over a maximum period of 28 days. Samples were taken immediately after preparation (day 0) and after 2, 7, 14, 21, and 28 days. Physicochemical stability was determined by ion-exchange high-performance liquid chromatography (IE-HPLC) and size-exclusion high-performance liquid chromatography (SE-HPLC) with ultraviolet detection, pH measurement and visual inspection for particles or colour changes. RESULTS In the IE-HPLC assay, peak areas and peak-to-peak area ratios remained unchanged over the whole study period, and showed no additional peaks of degraded daratumumab charge variants. In the SE-HPLC assay, neither a formation of aggregates nor of fragments was detected. Daratumumab monomer concentrations exceeded 95% of the initially measured concentrations over the entire test period. pH values remained constant. Test solutions remained clear, and no colour changes or visible particles were detected. All results were independent of storage conditions. CONCLUSION Daratumumab subcutaneous injection solution proved to be physicochemically stable in capped three-piece plastic syringes for at least 28 days when stored light protected at 2-8°C or at room temperature (22±2°C). For microbiological reasons aseptic preparation and refrigerated storage are recommended. In-use stability of ready-to-administer daratumumab subcutaneous syringes prepared under appropriate aseptic conditions is given for 28 days.
Collapse
Affiliation(s)
- Laura Knoll
- Pharmacy, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
| | - Judith Thiesen
- Pharmacy, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
| | - Martin D Klassen
- Institut für Umwelt & Energie Technik & Analytik e V (IUTA), Duisburg, Germany
| | - Lars M H Reinders
- Institut für Umwelt & Energie Technik & Analytik e V (IUTA), Duisburg, Germany
| | - Jochen Tuerk
- Institut für Umwelt & Energie Technik & Analytik e V (IUTA), Duisburg, Germany
| | - Irene Kraemer
- Pharmacy, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
| |
Collapse
|
3
|
Reinders LMH, Klassen MD, Jaeger M, Schmidt TC, Teutenberg T, Tuerk J. Quality Control of Personalized Drug Products - Identity and Quantity of Monoclonal Antibodies as Active Pharmaceutical Ingredient. J Pharm Sci 2023; 112:2142-2145. [PMID: 37343927 DOI: 10.1016/j.xphs.2023.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Revised: 06/14/2023] [Accepted: 06/14/2023] [Indexed: 06/23/2023]
Abstract
Deliberate underdosing occurred in personalized preparations of drugs such as monoclonal antibodies as the active pharmaceutical ingredient in the past. To ensure the required quality standard and to prevent future fraud attempts at an early stage, a HPLC-DAD-HRMS method was established. Thereby, identity and quantity of the active ingredients bevacizumab, rituximab and trastuzumab were determined. The analysis of ten samples from seven pharmacies fulfilled the quality criteria and were therefore not objectionable.
Collapse
Affiliation(s)
- Lars M H Reinders
- Institut für Umwelt & Energie, Technik & Analytik, Bliersheimer Str. 58-60, 47229 Duisburg, Germany; Hochschule Niederrhein (University of Applied Science), Reinarzstr. 49, 47805 Krefeld, Germany; University Duisburg-Essen, Faculty of Chemistry, Instrumental Analytical Chemistry, Universitätsstr. 5, 45141 Essen, Germany
| | - Martin D Klassen
- Institut für Umwelt & Energie, Technik & Analytik, Bliersheimer Str. 58-60, 47229 Duisburg, Germany
| | - Martin Jaeger
- Hochschule Niederrhein (University of Applied Science), Reinarzstr. 49, 47805 Krefeld, Germany
| | - Torsten C Schmidt
- University Duisburg-Essen, Faculty of Chemistry, Instrumental Analytical Chemistry, Universitätsstr. 5, 45141 Essen, Germany
| | - Thorsten Teutenberg
- Institut für Umwelt & Energie, Technik & Analytik, Bliersheimer Str. 58-60, 47229 Duisburg, Germany.
| | - Jochen Tuerk
- Institut für Umwelt & Energie, Technik & Analytik, Bliersheimer Str. 58-60, 47229 Duisburg, Germany
| |
Collapse
|
4
|
Reinders LMH, Klassen MD, Endres P, Krumm A, Jaeger M, Schmidt TC, Teutenberg T. Development of a Two-dimensional Liquid Chromatography High-Resolution Mass Spectrometry Method for the Characterization of Monoclonal Antibodies in Cell-Free Culture Supernatant via FcR Affinity Chromatography. Chromatographia 2022. [DOI: 10.1007/s10337-022-04228-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
5
|
Reinders LMH, Noelle D, Klassen MD, Jaeger M, Schmidt TC, Tuerk J, Teutenberg T. Development and validation of a method for airborne monoclonal antibodies to quantify workplace exposure. J Pharm Biomed Anal 2022; 221:115046. [PMID: 36152489 DOI: 10.1016/j.jpba.2022.115046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 09/06/2022] [Accepted: 09/11/2022] [Indexed: 10/31/2022]
Abstract
Modern therapy strategies are based on patient-specific treatment where the drug and dose are optimally adapted to the patient's needs. In recent drugs, monoclonal antibodies (mAbs) are increasingly used as active ingredients. Their patient-specific formulations are not part of the pharmaceutical industry's manufacturing process but are prepared from concentrates by pharmaceutical personnel. During the manufacturing process, however, active pharmaceutical ingredients are released in trace amounts or, in the case of accidents and spills, also in high concentrations. Regardless of the source of entry, mAbs can become airborne, be inhaled, and cause undesirable side-effects such as sensitization. To assess the risk for pharmaceutical personnel, a personal air sampling method was developed and validated for bevacizumab, cetuximab, daratumumab, omalizumab, rituximab and trastuzumab. The method is based on the combination of high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS). The analytical method achieves a limit of detection of 0.30-8.8 ng mL-1, recoveries of 83-96 % (intra-day assay) and 75-89 % (inter-day assay), with no detectable carry-over. A polycarbonate filter proved suitable for sampling airborne monoclonal antibodies, as it achieved 80-104 % recovery across all mAbs. It also showed concentration-independent desorption efficiency. The sampling duration can be up to 480 min without negatively affecting the recovery. MAbs are stable on the polycarbonate filter at 5 °C for 3 days (recovery: 94 % ± 5 %) and at - 20 °C for 14 days (recovery: 97 % ± 4 %). Our method demonstrated that there is a potential for release when handling monoclonal antibodies. However, this can be reduced below the limit of detection by using pressure equalization systems (spikes).
Collapse
Affiliation(s)
- Lars M H Reinders
- Institut für Energie und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229 Duisburg, Germany; Hochschule Niederrhein (University of Applied Science), Reinarzstr. 49, 47805 Krefeld, Germany; University Duisburg-Essen, Faculty of Chemistry, Instrumental Analytical Chemistry, Universitätsstr. 5, 45141 Essen, Germany
| | - Dennis Noelle
- Institut für Energie und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229 Duisburg, Germany; Hochschule Niederrhein (University of Applied Science), Reinarzstr. 49, 47805 Krefeld, Germany
| | - Martin D Klassen
- Institut für Energie und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229 Duisburg, Germany
| | - Martin Jaeger
- Hochschule Niederrhein (University of Applied Science), Reinarzstr. 49, 47805 Krefeld, Germany
| | - Torsten C Schmidt
- University Duisburg-Essen, Faculty of Chemistry, Instrumental Analytical Chemistry, Universitätsstr. 5, 45141 Essen, Germany
| | - Jochen Tuerk
- Institut für Energie und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229 Duisburg, Germany
| | - Thorsten Teutenberg
- Institut für Energie und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229 Duisburg, Germany.
| |
Collapse
|
6
|
Reinders LMH, Klassen MD, Teutenberg T, Jaeger M, Schmidt TC. Comparison of originator and biosimilar monoclonal antibodies using HRMS, Fc affinity chromatography, and 2D-HPLC. Anal Bioanal Chem 2022; 414:6761-6769. [PMID: 35895102 DOI: 10.1007/s00216-022-04236-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Revised: 07/06/2022] [Accepted: 07/15/2022] [Indexed: 11/30/2022]
Abstract
Due to the complex manufacturing process of therapeutic monoclonal antibodies, it is hardly possible to produce an identical copy of the original product (originator). Consequently, follow-on products (biosimilars) must demonstrate their efficacy being similar to the originator in terms of structure and function. During this process, a variety of analytical methods are required for this purpose. This study focuses on three particularly relevant analytical techniques: high-resolution mass spectrometry, fragment crystallisable (Fc) affinity chromatography, and two-dimensional peptide mapping. Each analytical method proved able to identify specific differences between originator and biosimilar. High-resolution mass spectrometry was used to characterize the glycan pattern. It was shown that a trastuzumab biosimilar did not have the G0:G0F sugar modification identified in the originator. The application of affinity chromatography to rituximab showed that originator and biosimilar interacted differently with the immobilized Fc receptor. Furthermore, 2D-HPLC peptide mapping demonstrated the influence of orthogonality of separation dimensions, leading to differentiation of a rituximab originator and biosimilar.
Collapse
Affiliation(s)
- Lars M H Reinders
- Institut Für Energie- und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229, Duisburg, Germany
- Hochschule Niederrhein (University of Applied Science), Reinarzstr. 49, 47805, Krefeld, Germany
- Instrumental Analytical Chemistry, Faculty of Chemistry, University Duisburg-Essen, Universitätsstr. 5, 45141, Essen, Germany
| | - Martin D Klassen
- Institut Für Energie- und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229, Duisburg, Germany
| | - Thorsten Teutenberg
- Institut Für Energie- und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229, Duisburg, Germany.
| | - Martin Jaeger
- Hochschule Niederrhein (University of Applied Science), Reinarzstr. 49, 47805, Krefeld, Germany
| | - Torsten C Schmidt
- Instrumental Analytical Chemistry, Faculty of Chemistry, University Duisburg-Essen, Universitätsstr. 5, 45141, Essen, Germany
| |
Collapse
|
7
|
Reinders LMH, Klassen MD, Teutenberg T, Jaeger M, Schmidt TC. Development of a multidimensional online method for the characterization and quantification of monoclonal antibodies using immobilized flow-through enzyme reactors. Anal Bioanal Chem 2021; 413:7119-7128. [PMID: 34628527 DOI: 10.1007/s00216-021-03683-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 09/14/2021] [Accepted: 09/20/2021] [Indexed: 01/06/2023]
Abstract
Complete characterization and quantification of monoclonal antibodies often rely on enzymatic digestion with trypsin. In order to accelerate and automate this frequently performed sample preparation step, immobilized enzyme reactors (IMER) compatible with standard HPLC systems were used. This allows an automated online approach in all analytical laboratories. We were able to demonstrate that the required digestion time for the model monoclonal antibody rituximab could be reduced to 20 min. Nevertheless, a previous denaturation of the protein is required, which also needs 20 min. Recoveries were determined at various concentrations and were 100% ± 1% at 100 ng on column, 96% ± 7% at 250 ng on column and 98% ± 2% at 450 ng on column. Despite these good recoveries, complete digestion was not achieved, resulting in a poorer limit of quantification. This is 50 ng on column under optimized IMER conditions, whereas an offline digest on the same system achieved 0.3 ng on column. Furthermore, our work revealed that TRIS buffers, when used with an IMER system, led to alteration of the peptides and induced modifications in the peptides. Therefore, the addition of TRIS should be avoided when working at elevated temperatures of about 60 °C. Nevertheless, our results have shown that the recovery is not significantly influenced whether TRIS is used or not (recovery: 96 ± 7% with TRIS vs. 100 ± 9% without TRIS).
Collapse
Affiliation(s)
- Lars M H Reinders
- Institut für Energie und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229, Duisburg, Germany.,Hochschule Niederrhein, University of Applied Science, Reinarzstr. 49, 47805, Krefeld, Germany.,Faculty of Chemistry, Instrumental Analytical Chemistry, University Duisburg-Essen, Universitätsstr. 5, 45141, Essen, Germany
| | - Martin D Klassen
- Institut für Energie und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229, Duisburg, Germany
| | - Thorsten Teutenberg
- Institut für Energie und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), Bliersheimer Str. 58-60, 47229, Duisburg, Germany.
| | - Martin Jaeger
- Hochschule Niederrhein, University of Applied Science, Reinarzstr. 49, 47805, Krefeld, Germany
| | - Torsten C Schmidt
- Faculty of Chemistry, Instrumental Analytical Chemistry, University Duisburg-Essen, Universitätsstr. 5, 45141, Essen, Germany
| |
Collapse
|